GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSL:BGBIO) » Definitions » Net Interest Income (for Banks)

BerGenBio ASA (OSL:BGBIO) Net Interest Income (for Banks)


View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


BerGenBio ASA Business Description

Industry
Traded in Other Exchanges
Address
Mollendalsbakken 9, Bergen, NOR, 5009
BerGenBio ASA is a clinical-stage biopharmaceutical Company focused on developing novel medicines for aggressive diseases. The company's clinical asset, bemcentinib, targeting the receptor tyrosine kinase AXL, is currently in development in a Ph1b/2a study in 1L STK 11 mutated NSCLC and preclinical development for severe respiratory infections.